HomeNAN • ASX
Nanosonics Ltd.
$3.28
Jan 13, 7:00:00 PM GMT+11 · AUD · ASX · Disclaimer
StockAU listed securityAU headquartered
Previous close
$3.11
Day range
$3.07 - $3.30
Year range
$2.59 - $4.45
Market cap
995.64M AUD
Avg Volume
325.14K
P/E ratio
78.10
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD)Jun 2024Y/Y change
Revenue
45.19M7.04%
Operating expense
31.92M8.26%
Net income
3.40M-28.48%
Net profit margin
7.53-33.19%
Earnings per share
——
EBITDA
3.66M-6.56%
Effective tax rate
16.25%—
Total assets
Total liabilities
(AUD)Jun 2024Y/Y change
Cash and short-term investments
129.55M15.51%
Total assets
237.34M7.92%
Total liabilities
55.14M-1.65%
Total equity
182.20M—
Shares outstanding
303.00M—
Price to book
5.18—
Return on assets
2.71%—
Return on capital
3.36%—
Net change in cash
(AUD)Jun 2024Y/Y change
Net income
3.40M-28.48%
Cash from operations
6.88M-8.75%
Cash from investing
-630.00K11.14%
Cash from financing
-773.00K-14.77%
Net change in cash
5.62M-12.72%
Free cash flow
3.51M-27.58%
About
Nanosonics is a ASX-listed company in the healthcare industry which manufactures and distributes ultrasound probe disinfectors and other related technologies. It has offices in Australia, the U.S. and Canada, the United Kingdom and Europe, employing more than 300 people. The company’s Trophon is the product used to reduce the spread of Healthcare Acquired Infections. Its Trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection. Wikipedia
Founded
2001
Employees
466
Search
Clear search
Close search
Google apps
Main menu